MMP9 and colitis: The relevance of MMP9 in the pathology of certain inflammatory and oncology indications has been demonstrated by reports showing that mmp9-/- mice exhibited decreased disease severity in preclinical models of colitis and rheumatoid arthritis, and also displayed reduced tumor growth and/or reduced metastases in several cancer models [1, 66, 74–81].